Company Performance Metrics
- Kevin Dunworth: Founder and CEO
SpineSmith designs, develops, and markets implants and biologics for surgical fixation, correction, and tissue regeneration of the spine. Its products include cervical interbody fusion devices, anterior lumbar interbody fusion devices, vertebral body replacement and intervertebral body fusion devices, anterior cervical plate systems, transforaminal
lumbar interbody fusion devices, and transforaminal posterior lumbar interbody fusion devices.
SpineSmith's products also comprise regenerative cell products for orthopedics and spinal procedures; and whole-body advanced vibration therapy devices for advance healing applications. Moreover, it engages in the development, testing, and regulatory processing of facet fixation devices, soft tissue anchors, biologically active artificial discs, cervical and lumbar disc injection therapies, proprietary disc injection devices, distraction pin aspiration devices, in situ fusion with natural disc properties, and biologically enhanced implants.
SpineSmith sells its products through distributors. It began operation in 2006, with its headquarters in Austin in Texas as a subsidiary of VCD Medical.